» Articles » PMID: 34285741

New-onset Restless Leg Syndrome in a COVID-19 Patient: a Case Report with Literature Review

Overview
Journal Pan Afr Med J
Date 2021 Jul 21
PMID 34285741
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Restless leg syndrome (RLS) is a sleep disorder characterized by the sudden urge to move the lower limbs during periods of rest accompanied by an unpleasant sensation like tingling or burning in the legs. Often, this urge is partially relieved by the movement of legs. However, it causes disturbance of sleep leading to daytime fatigue. Herein, we present an unusual case of new-onset of restless leg syndrome in a COVID-19 infected patient who presented three weeks after an uncomplicated delivery via caesarean section. The patient was managed with sleep hygiene measures, oral iron and vitamin C tablets apart from general COVID-19 management medications, subsequently leading to significant improvements. Here we have discussed possible associated factors, pathophysiological mechanisms and management of RLS in the case of COVID infected individuals.

Citing Articles

[Cognitive disorders and sleep disturbances in long COVID].

Schilling C, Meyer-Lindenberg A, Schweiger J Nervenarzt. 2022; 93(8):779-787.

PMID: 35576015 PMC: 9109661. DOI: 10.1007/s00115-022-01297-z.


Case report of restless anal syndrome as restless legs syndrome variant after COVID-19.

Nakamura I, Itoi T, Inoue T BMC Infect Dis. 2021; 21(1):993.

PMID: 34556029 PMC: 8460186. DOI: 10.1186/s12879-021-06683-7.

References
1.
Najjar S, Najjar A, Chong D, Pramanik B, Kirsch C, Kuzniecky R . Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020; 17(1):231. PMC: 7406702. DOI: 10.1186/s12974-020-01896-0. View

2.
Trenkwalder C, Allen R, Hogl B, Paulus W, Winkelmann J . Restless legs syndrome associated with major diseases: A systematic review and new concept. Neurology. 2016; 86(14):1336-1343. PMC: 4826337. DOI: 10.1212/WNL.0000000000002542. View

3.
Karadas O, Ozturk B, Sonkaya A . A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci. 2020; 41(8):1991-1995. PMC: 7316428. DOI: 10.1007/s10072-020-04547-7. View

4.
Allen R, Picchietti D, Hening W, Trenkwalder C, Walters A, Montplaisi J . Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003; 4(2):101-19. DOI: 10.1016/s1389-9457(03)00010-8. View

5.
Zhou C, Chen Y, Ji Y, He X, Xue D . Increased Serum Levels of Hepcidin and Ferritin Are Associated with Severity of COVID-19. Med Sci Monit. 2020; 26:e926178. PMC: 7526336. DOI: 10.12659/MSM.926178. View